Return to search
Hochdosis-Chemotherapie gefolgt von einer myeloablativen Hochdosis-Radioimmuntherapie (HD-RAIT) mit Iod-131-Rituximab und peripherer Stammzelltransplantation (SCTx) bei primär refraktären und rezidivierten Non-Hodgkin-Lymphomen / High Dose Chemotherapy followed by a myeloablative radioimmunotherapy and stem cell transplantation with I-131-anti CD20 Antibody in relapsed and primary refractory B- Cell lymphoma
No description available.
Identifer | oai:union.ndltd.org:uni-goettingen.de/oai:ediss.uni-goettingen.de:11858/00-1735-0000-0006-B187-0 |
Date | 21 February 2011 |
Creators | Mehari, Symon |
Contributors | Meller, Johannes Prof. Dr. |
Source Sets | Georg-August-Universität Göttingen |
Language | German |
Detected Language | English |
Type | doctoralThesis |
Format | application/pdf |
Rights | http://creativecommons.org/licenses/by-nc-nd/3.0/ |
Page generated in 0.0014 seconds